PReS13-SPK-1408: New EU Scientific Guidelines for JIA, SLE and GIOP From the European Medicines Agency

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-11-s2-i16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

FDA Reform and the European Medicines Evaluation Agency

Harvard Law Review
Law
1995English

Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency

Children
2015English

Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency

Frontiers in Plant Science
Plant Science
2020English

PReS13-SPK-1028: Activity and Damage - We Have to Measure Them

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

PReS13-SPK-1107: Development of an Academic Pediatric Rheumatology Program

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

PReS13-SPK-1472: Science of Muscle Training in Inflammatory Disease

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

European Medicines Agency Policies for Clinical Trials Leave Women Unprotected

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy